Home / Business / Recommended Mix Momentum Stocks: Liberty Global (NASDAQ:LBTYA), Aerie Pharmaceuticals (NASDAQ:AERI)

Recommended Mix Momentum Stocks: Liberty Global (NASDAQ:LBTYA), Aerie Pharmaceuticals (NASDAQ:AERI)

Liberty Global plc (NASDAQ:LBTYA) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it -0.96% to close at $32.12 with the total traded volume of 2.09 Million shares. Liberty Global plc reported that a multi-year alliance with Netflix Inc., which will lead to Netflix’s content being made accessible to Liberty Global video consumers across over 30 countries about the world.

The launch of the Netflix service on Liberty Global’s advanced digital television platforms will bring critically acclaimed original Netflix series and wide range of movies and kids’ programming to Liberty Global’s video subscribers across Europe, Latin America and the Caribbean.

The alliance follows the successful UK launch of Netflix on Virgin Media in 2013. It is the recent example of Liberty Global’s commitment to its consumers to bring them the very best in entertainment, all conveniently accessible on their TV, tablet or mobile phone. Liberty Global’s digital TV platforms, like Horizon, bring together the world of broadcast, on demand and online content in a fully integrated and multi-device user experience. The firm has institutional ownership of 95.80%, while insider ownership included 1.20%. Its price to sales ratio ended at 2.04. LBTYA attains analyst recommendation of 2.00 with week performance of -1.89%.

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) [Trend Analysis] increased reacts as active mover, shares a gain 7.53% to traded at $21.13 and the percentage gap among open changing to regular change was 7.63%. Aerie Pharmaceuticals Inc. (AERI) treatment for lowering fluid pressure inside the eyeball yielded promising results. Aerie shares jumped 61% to $34 on heavy volume. In a late-stage clinical trial, the firm stated its treatment Roclatan importantly lowered intraocular pressures in treated patients compared to those treated with latanoprost or Rhopressa, another Aerie product. The firm’s current ratio calculated as 7.70 for the most recent quarter.


About Devon Leftovich

Devon Leftovich is an entrepreneur. He has been writing and editing professionally for over six years. He is admin editor and senior content writer of SWR. However, he has determined to give investors something rare, a dignified partner who can manage money with integrity and a clear conscience about the degree of due diligence behind investment decisions. He said, "I love the financial world because it is like one big puzzle and I hope we the SWR help each other out to solve the puzzle to help us realize our dreams." Interests: Analysis of different Companies; including news and analyst rating updates. He performs analysis of Companies and publicizes important information for investor/traders community. Stocks long-term and short-term holding views, Tech Stocks

Check Also

Stocks Retreat on New Development: Deutsche Bank (NYSE:DB), Ingram Micro (NYSE:IM)

Shares of Deutsche Bank AG (NYSE:DB) [Trend Analysis] swings enthusiastically in regular trading session, it a decrease …

Leave a Reply

Your email address will not be published. Required fields are marked *